Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
Work
Year: 2009
Type: article
Abstract: To determine whether (1) immunohistochemical (IHC) HER2 status (ie, 2+ or 3+), (2) degree of fluorescence in situ hybridization (FISH) amplification according to (2a) HER2/CEP17 ratio or (2b) HER2 gen... more
Source: Journal of Clinical Oncology
Authors Mitch Dowsett, Marion Procter, Worta McCaskill‐Stevens, Evandro de Azambuja, Urania Dafni +9 more
Institutions Université Libre de Bruxelles, Institut Jules Bordet, National Institutes of Health, National Cancer Institute
Cites: 27
Cited by: 176
Related to: 10
FWCI: 8.179
Citation percentile (by year/subfield): 95.24
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Life below water
Open Access status: green